ATC level 4
J05AFDirect acting antiviral, subgroup J05AF
- Molecules
- 8
- Subgroups
- 8
ATC J05AF (Direct acting antiviral, subgroup J05AF) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 8 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J05AF.
- AbacavirHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor4 presentations2 brandsJ05AF06
- Adefovir dipivoxilHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentationJ05AF08
- EmtricitabineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations2 brandsJ05AF09
- EntecavirHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor5 presentations4 brandsJ05AF10
- LamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor7 presentations4 brandsJ05AF05
- Tenofovir alafenamideHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AF13
- Tenofovir disoproxilOrphanHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor9 presentations4 brandsJ05AF07
- ZidovudineOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6 presentations1 brandJ05AF01
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.